erlotinib (Imagine Institut des Maladies Genetiques Necker Enfants Malades)

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug Nameerlotinib (Imagine Institut des Maladies Genetiques Necker Enfants Malades)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsPachyonychia Congenita
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImagine Institute
China Registration ClassN/A

Develop Information

Active CompaniesImagine Institute
Inactive CompaniesN/A
Active IndicationsPachyonychia Congenita
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A